| Literature DB >> 30271318 |
Rosaleena Mohanty1,2, Anita M Sinha1,3, Alexander B Remsik1,4, Keith C Dodd1,3, Brittany M Young5,6, Tyler Jacobson1,7, Matthew McMillan1,3, Jaclyn Thoma1,6, Hemali Advani1, Veena A Nair1, Theresa J Kang1, Kristin Caldera8, Dorothy F Edwards4, Justin C Williams3, Vivek Prabhakaran1,3,5,6,9.
Abstract
The primary goal of this work was to apply data-driven machine learning regression to assess if resting state functional connectivity (rs-FC) could estimate measures of behavioral domains in stroke subjects who completed brain-computer interface (BCI) intervention for motor rehabilitation. The study cohort consisted of 20 chronic-stage stroke subjects exhibiting persistent upper-extremity motor deficits who received the intervention using a closed-loop neurofeedback BCI device. Over the course of this intervention, resting state functional MRI scans were collected at four distinct time points: namely, pre-intervention, mid-intervention, post-intervention and 1-month after completion of intervention. Behavioral assessments were administered outside the scanner at each time-point to collect objective measures such as the Action Research Arm Test, Nine-Hole Peg Test, and Barthel Index as well as subjective measures including the Stroke Impact Scale. The present analysis focused on neuroplasticity and behavioral outcomes measured across pre-intervention, post-intervention and 1-month post-intervention to study immediate and carry-over effects. Rs-FC, changes in rs-FC within the motor network and the behavioral measures at preceding stages were used as input features and behavioral measures and associated changes at succeeding stages were used as outcomes for machine-learning-based support vector regression (SVR) models. Potential clinical confounding factors such as age, gender, lesion hemisphere, and stroke severity were included as additional features in each of the regression models. Sequential forward feature selection procedure narrowed the search for important correlates. Behavioral outcomes at preceding time-points outperformed rs-FC-based correlates. Rs-FC and changes associated with bilateral primary motor areas were found to be important correlates of across several behavioral outcomes and were stable upon inclusion of clinical variables as well. NIH Stroke Scale and motor impairment severity were the most influential clinical variables. Comparatively, linear SVR models aided in evaluation of contribution of individual correlates and seed regions while non-linear SVR models achieved higher performance in prediction of behavioral outcomes.Entities:
Keywords: brain-computer interface; functional connectivity; machine learning; motor impairment; stroke recovery; support vector regression
Year: 2018 PMID: 30271318 PMCID: PMC6142044 DOI: 10.3389/fnins.2018.00624
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Figure 1Study paradigm. The time-points at which neuroimaging and behavioral data were collected are represented by - T1: Control baseline 1, T2: Control baseline 2, T3: Control baseline 3, T4: Intervention baseline T5: Mid-intervention, T6: Post-intervention, and T7: 1-month post-intervention.
Demographic and clinical characteristics of the study cohort.
| Number of stroke subjects | 20 |
| Chronicity | Chronic (>6 months since stroke onset) |
| Age (mean ± std. dev in years) | 62.4 ± 14.27 |
| Gender | 8 Females, 12 Males |
| Lesion hemisphere | 8 Left, 12 Right |
| Stroke severity (mean NIHSS ± std. dev) | 3.75 ± 3.5 |
| Motor impairment severity | 11 Severe, 9 Moderate |
| Time since stroke (mean ± std. dev in months) | 37.65 ± 40.84 |
| Post-stroke handedness | 16 Right, 2 Left, 2 Ambidextrous |
Summary of all the behavioral assessments used as outcomes.
| ARAT(U): Action Research Arm Test for the upper extremity unaffected by stroke | Objective |
| ARAT(A): Action Research Arm Test for the upper extremity affected by stroke | Objective |
| 9HPT(U): 9-Hole Peg Test for the upper extremity unaffected by stroke | Objective |
| 9HPT(A): 9-Hole Peg Test for the upper extremity affected by stroke | Objective |
| BI: Barthel Index | Objective |
| SIS(ADL): Activities of daily life domain of Stroke Impact Scale | Subjective |
| SIS (HF): Hand function domain of Stroke Impact Scale | Subjective |
| SIS(Mob): Mobility domain of Stroke Impact Scale | Subjective |
| SIS(PS): Physical strength domain of Stroke Impact Scale | Subjective |
Figure 2Steps for individual subject analysis are shown below. (A) rs-FC correlates of behavior: (a) raw rs-fMRI (top) from pre-, post- and 1-month post-interventions were preprocessed (bottom); (b) 8 seed regions were chosen from the motor network to compute rs-FC at each time-point; (c) 8 × 8 rs-FC matrix was computed and corresponding behavioral scores were transformed as needed for each time-point; (d) rs-FC reflected in the lower triangle of 8 × 8 matrix was vectorized into 28 unique correlation coefficients per subject and 8 distinct behavioral measures were aggregated for group-level analysis. (B) Δrs-FC correlates of Δ behavior: (a) raw rs-fMRI (top) from pre-, post- and 1-month post-interventions were preprocessed (bottom); (b) 8 seed regions were chosen from the motor network to compute rs-FC at each time-point; (c) 8 × 8 rs-FC matrix was computed and corresponding behavioral scores were transformed as needed for a preceding time-point; (d) 8 × 8 rs-FC matrix was computed and corresponding behavioral scores were transformed as needed for a succeeding time-point; (e) change in rs-FC and behavioral scores were calculated between the two time-points; (f) change in rs-FC reflected in the lower triangle of 8 × 8 matrix was vectorized into 28 unique correlation coefficients per subject and change in 8 distinct behavioral measures were aggregated for group-level analysis. (C) behavioral correlates at preceding time-point of behavior at succeeding time-point: transformed scores for 8 behavioral measures at pre-, post- and 1-month post-interventions were aggregated for group-level analysis.
Figure 3Regions of interest in the motor network included four bilateral seeds: M1 (yellow), PMC (blue), SMA (green), and Thalamus (red).
Shorthand representation of the eight ROIs in the motor network used for the analysis is presented below.
| Left primary motor cortex | L.M1 | −39 | −22 | 57 |
| Right primary motor cortex | R.M1 | 40 | −23 | 55 |
| Left premotor cortex | L.PMC | −48 | 1 | 36 |
| Right premotor cortex | R.PMC | 58 | 1 | 35 |
| Left supplementary motor area | L.SMA | −6 | −14 | 53 |
| Right supplementary motor area | R.SMA | 8 | −14 | 52 |
| Left thalamus | L.Thal | −8 | −26 | 12 |
| Right thalamus | R.Thal | 8 | −26 | 12 |
Figure 4The overview of group-level analysis is provided here. (A) rs-FC correlates of behavior: (a) aggregated data from single-subject analysis gave 28 rs-FC features for each of the 20 subjects; (b) SFS was used to select specific correlates corresponding to each behavioral outcome; (c) aggregated behavioral scores for 20 subjects served as outcomes in separate models; (d) data from (b) and (c) were fed into the SVR model; (e) linear (top) and non-linear (bottom) kernels were specified to perform regression. Steps (a through e) were repeated by adding identified clinical variables to rs-FC data as input features. (B) Δrs-FC correlates of Δbehavior: (a) aggregated data from single-subject analysis gave 28 change in rs-FC features for each of the 20 subjects between pairs of time-points; (b) SFS was used to select specific correlates corresponding to each behavioral outcome; (c) aggregated change in behavioral scores between corresponding pair of time-points for 20 subjects served as outcomes in separate models; (d) data from (b) and (c) were fed into the SVR model; (e) linear (top) and non-linear (bottom) kernels were specified to perform regression. Steps (a–e) were repeated by adding identified clinical variables to change in rs-FC data as input features. (C) behavioral correlates at preceding time-point of behavior at succeeding time-point: (a) aggregated behavioral scores from a preceding time point gave 8 distinct measures; (b) aggregated behavioral scores from a succeeding time-point gave the corresponding 8 measures; (c) data from steps (a) and (b) were fed to the SVR model; (d) linear (top) and non-linear (bottom) kernels were specified to perform regression.
Linear-kernel SVR performances based on leave-one out cross-validation to correlate rs-FC at preceding time-point with behavioral measures at succeeding time-point are presented.
| 9HPT(A) | 9 | 110.93 | 0.21 | 14 | 116.69 | 0.14 | 6 | 109.25 | 0.25 |
| 9HPT(U) | 5 | 4.2 | 0.27 | 3 | 4.05 | 0.26 | 6 | 2.86 | 0.63 |
| ARAT(A) | 2 | 20.58 | 0.33 | 6 | 17.87 | 0.49 | 4 | 15.48 | 0.61 |
| BI | 3 | 8.01 | 0.24 | 5 | 6.31 | 0.31 | 11 | 6.39 | 0.3 |
| SIS(ADL) | 4 | 10.93 | 0.14 | 4 | 10.62 | 0.51 | 5 | 109.25 | 0.25 |
| SIS(HF) | 4 | 31.81 | 0.37 | 6 | 26.84 | 0.36 | 5 | 33.47 | 0.64 |
| SIS(Mob) | 6 | 7.88 | 0.19 | 8 | 13.17 | 0.10 | 4 | 11.34 | 0.34 |
| SIS(PS) | 10 | 18.44 | 0.18 | 5 | 11.93 | 0.47 | 4 | 11.7 | 0.49 |
| 9HPT(A) | 10 | 69.627 | 0.69 | 14 | 71.349 | 0.68 | 7 | 61.391 | 0.76 |
| 9HPT(U) | 4 | 4.187 | 0.28 | 4 | 3.822 | 0.34 | 9 | 1.508 | 0.9 |
| ARAT(A) | 2 | 5.143 | 0.96 | 4 | 5.723 | 0.95 | 2 | 7.009 | 0.92 |
| BI | 7 | 9.452 | 0.43 | 7 | 13.378 | 0.22 | 12 | 14.099 | 0.13 |
| SIS(ADL) | 7 | 16.146 | 0.78 | 2 | 23.484 | 0.51 | 11 | 15.1018 | 0.8 |
| SIS(HF) | 5 | 9.766 | 0.03 | 8 | 9.4 | 0.54 | 5 | 10.514 | 0.43 |
| SIS(Mob) | 1 | 16.361 | 0.37 | 4 | 13.523 | 0.32 | 6 | 12.528 | 0.41 |
| SIS(PS) | 4 | 6.796 | 0.41 | 7 | 4.591 | 0.64 | 10 | 3.817 | 0.75 |
Specific correlates are listed in Table .
(
) = significant against chance-level based on permutation-test (p < 0.05); T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.
List of rs-FC correlates of behavior between all pairs of time-points identified by using linear-kernel SVR are presented below.
| 1 | L.SMA-R.M1 | L.SMA-R.PMC | R.PMC-L.PMC | R.PMC-R.M1 | L.SMA-L.PMC | R.PMC-R.M1 | R.SMA-R.M1 | L.SMA-R.M1 |
| 2 | R.SMA-R.M1 | R.PMC-R.M1 | L.SMA-R.M1 | L.Thal-L.M1 | R.SMA-R.M1 | R.SMA-L.SMA | L.Thal-R.SMA | R.PMC-L.PMC |
| 3 | R.M1-L.M1 | R.SMA-R.PMC | R.SMA-L.M1 | L.SMA-L.M1 | L.Thal-R.PMC | R.SMA-L.M1 | R.Thal-L.SMA | |
| 4 | R.PMC-R.M1 | L.PMC-R.M1 | R.M1-L.M1 | R.M1-L.M1 | L.Thal-R.M1 | L.SMA-L.PMC | ||
| 5 | R.Thal-L.Thal | L.Thal-L.M1 | R.Thal-R.PMC | L.Thal-L.M1 | ||||
| 6 | R.Thal-L.M1 | R.SMA-R.M1 | L.PMC-L.M1 | |||||
| 7 | R.SMA-R.PMC | R.M1-L.M1 | ||||||
| 8 | R.PMC-L.PMC | L.Thal-R.M1 | ||||||
| 9 | L.Thal-L.M1 | R.PMC-L.PMC | ||||||
| 10 | R.Thal-L.M1 | |||||||
| 1 | L.SMA-R.M1 | L.Thal-L.SMA | R.SMA-R.PMC | R.Thal-L.M1 | R.SMA-R.M1 | R.PMC-R.M1 | R.Thal-R.PMC | L.PMC-L.M1 |
| 2 | R.SMA-R.M1 | R.SMA-L.SMA | L.SMA-R.M1 | R.PMC-R.M1 | L.PMC-L.M1 | L.SMA-L.M1 | R.SMA-R.M1 | R.SMA-R.M1 |
| 3 | R.PMC-R.M1 | R.Thal-L.PMC | R.SMA-R.M1 | L.Thal-R.M1 | R.M1-L.M1 | R.SMA-L.SMA | R.Thal-L.Thal | R.Thal-L.SMA |
| 4 | R.Thal-L.SMA | R.PMC-R.M1 | R.SMA-L.M1 | L.SMA-L.M1 | R.SMA-L.M1 | L.Thal-R.M1 | L.Thal-L.M1 | |
| 5 | R.M1-L.M1 | R.PMC-L.PMC | L.Thal-R.PMC | L.Thal-R.PMC | R.M1-L.M1 | R.Thal-L.M1 | ||
| 6 | R.SMA-R.PMC | L.PMC-L.M1 | R.SMA-L.SMA | L.SMA-L.PMC | ||||
| 7 | L.Thal-R.M1 | R.Thal-L.SMA | ||||||
| 8 | R.Thal-L.Thal | R.Thal-R.PMC | ||||||
| 9 | R.Thal-R.SMA | |||||||
| 10 | R.Thal-R.M1 | |||||||
| 11 | R.PMC-L.PMC | |||||||
| 12 | R.Thal-L.M1 | |||||||
| 13 | L.SMA-R.PMC | |||||||
| 14 | L.Thal-L.M1 | |||||||
| 1 | R.PMC-R.M1 | L.Thal-R.PMC | R.PMC-R.M1 | L.SMA-R.M1 | R.PMC-L.M1 | R.PMC-R.M1 | R.Thal-L.SMA | L.Thal-R.M1 |
| 2 | R.PMC-L.PMC | L.SMA-R.PMC | R.Thal-R.PMC | R.PMC-L.M1 | R.Thal-L.PMC | R.Thal-L.PMC | R.Thal-L.PMC | L.Thal-L.SMA |
| 3 | R.Thal-R.PMC | R.SMA-L.M1 | L.SMA-R.PMC | R.SMA-R.PMC | L.SMA-R.M1 | R.SMA-L.PMC | R.Thal-L.M1 | L.SMA-R.PMC |
| 4 | R.M1-L.M1 | R.Thal-L.M1 | R.M1-L.M1 | L.SMA-R.PMC | R.Thal-R.M1 | R.SMA-L.SMA | R.PMC-L.M1 | R.SMA-R.M1 |
| 5 | L.SMA-R.PMC | R.Thal-R.M1 | R.Thal-R.PMC | L.Thal-L.SMA | R.Thal-R.PMC | |||
| 6 | R.SMA-L.PMC | R.PMC-L.M1 | L.PMC-L.M1 | |||||
| 7 | R.SMA-R.PMC | |||||||
| 8 | R.PMC-R.M1 | |||||||
| 9 | R.M1-L.M1 | |||||||
| 10 | L.Thal-L.M1 | |||||||
| 11 | R.Thal-L.PMC | |||||||
| 1 | Motor Imp. | L.PMC-R.M1 | Motor Imp. | TSS | Motor Imp. | L.Thal-R.PMC | NIHSS | Motor Imp. |
| 2 | NIHSS | Age | NIHSS | R.SMA-R.PMC | L.SMA-R.PMC | Lesion Hemi | R.Thal-L.SMA | |
| 3 | Lesion Hemi | L.SMA-L.M1 | R.Thal-R.PMC | R.M1-L.M1 | R.SMA-R.M1 | NIHSS | ||
| 4 | R.M1-L.M1 | NIHSS | Motor Imp. | R.PMC-R.M1 | L.Thal-R.PMC | Age | ||
| 5 | R.SMA-R.PMC | Lesion Hemi | R.Thal-R.M1 | L.SMA-R.M1 | ||||
| 6 | L.SMA-R.M1 | R.Thal-L.M1 | R.Thal-L.PMC | |||||
| 7 | TSS | R.PMC-R.M1 | L.PMC-L.M1 | |||||
| 8 | R.Thal-L.Thal | |||||||
| 9 | R.SMA-R.M1 | |||||||
| 10 | R.PMC-R.M1 | |||||||
| 1 | Motor Imp. | R.SMA-L.SMA | Motor Imp. | R.SMA-L.M1 | R.PMC-L.M1 | R.PMC-R.M1 | Motor Imp. | TSS |
| 2 | NIHSS | R.SMA-L.M1 | NIHSS | R.Thal-L.M1 | Motor Imp. | L.SMA-L.M1 | R.Thal-L.Thal | Motor Imp. |
| 3 | Lesion Hemi | R.PMC-R.M1 | L.Thal-R.PMC | R.SMA-R.M1 | R.SMA-L.M1 | L.Thal-R.SMA | Age | |
| 4 | TSS | NIHSS | R.Thal-R.PMC | R.PMC-L.PMC | L.SMA-L.PMC | L.Thal-R.PMC | R.PMC-R.M1 | |
| 5 | R.SMA-R.M1 | R.SMA-L.M1 | L.Thal-R.M1 | R.PMC-L.PMC | ||||
| 6 | R.M1-L.M1 | L.PMC-L.M1 | R.Thal-L.PMC | R.M1-L.M1 | ||||
| 7 | L.PMC-L.M1 | TSS | NIHSS | R.SMA-R.M1 | ||||
| 8 | L.SMA-R.M1 | NIHSS | ||||||
| 9 | L.Thal-L.M1 | |||||||
| 10 | R.Thal-L.SMA | |||||||
| 11 | R.Thal-L.PMC | |||||||
| 12 | R.Thal-R.SMA | |||||||
| 13 | R.SMA-L.M1 | |||||||
| 14 | R.PMC-R.M1 | |||||||
| 1 | Motor Imp. | L.Thal-L.M1 | Motor Imp. | R.PMC-L.M1 | Motor Imp. | R.Thal-L.PMC | L.SMA-L.PMC | Motor Imp. |
| 2 | NIHSS | L.Thal-R.SMA | NIHSS | R.SMA-R.PMC | L.SMA-L.PMC | R.Thal-L.SMA | R.SMA-L.SMA | R.Thal-L.PMC |
| 3 | Lesion Hemi | L.Thal-R.PMC | TSS | TSS | R.Thal-L.M1 | Motor Imp. | R.PMC-L.PMC | |
| 4 | R.SMA-L.PMC | R.Thal-L.M1 | L.SMA-R.M1 | R.Thal-L.PMC | R.PMC-L.PMC | L.Thal-R.M1 | R.Thal-R.M1 | |
| 5 | R.PMC-L.PMC | R.SMA-L.M1 | NIHSS | NIHSS | L.Thal-L.M1 | R.SMA-R.M1 | R.Thal-R.PMC | |
| 6 | L.SMA-R.PMC | NIHSS | L.SMA-L.PMC | R.PMC-L.M1 | R.PMC-L.M1 | R.Thal-R.SMA | ||
| 7 | R.PMC-R.M1 | Gender | R.Thal-R.M1 | R.PMC-L.PMC | Age | |||
| 8 | L.Thal-L.SMA | L.PMC-L.M1 | NIHSS | TSS | ||||
| 9 | R.SMA-R.PMC | R.PMC-R.M1 | L.Thal-R.SMA | R.PMC-R.M1 | ||||
| 10 | R.SMA-L.M1 | R.Thal-R.PMC | R.M1-L.M1 | |||||
| 11 | R.Thal-L.PMC | NIHSS | ||||||
| 12 | R.SMA-R.M1 | |||||||
T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.
Linear-kernel SVR performances based on leave-one out cross-validation to correlate Δrs-FC between two time-points with Δ behavioral measures between corresponding time-points are presented.
| Δ9HPT(A) | 3 | 110.93 | 0.22 | 1 | 116.69 | 0.14 | 4 | 109.25 | 0.25 |
| Δ9HPT(U) | 1 | 4.2 | 0.28 | 1 | 4.05 | 0.26 | 6 | 2.86 | 0.63 |
| ΔARAT(A) | 7 | 20.58 | 0.33 | 4 | 17.87 | 0.49 | 6 | 15.48 | 0.61 |
| ΔBI | 5 | 8.01 | 0.18 | 5 | 0.05 | 0.53 | 6 | 6.39 | 0.3 |
| ΔSIS(ADL) | 2 | 10.93 | 0.24 | 5 | 10.62 | 0.51 | 8 | 0.08 | 0.73 |
| ΔSIS(HF) | 5 | 8.52 | 0.26 | 4 | 26.84 | 0.36 | 6 | 33.47 | 0.42 |
| ΔSIS(Mob) | 4 | 7.88 | 0.37 | 2 | 13.17 | 0.1 | 3 | 11.34 | 0.34 |
| ΔSIS(PS) | 3 | 18.44 | 0.2 | 3 | 11.93 | 0.47 | 6 | 0.81 | 0.2 |
| Δ9HPT(A) | 5 | 69.63 | 0.69 | 3 | 71.35 | 0.68 | 3 | 61.39 | 0.76 |
| Δ9HPT(U) | 3 | 4.19 | 0.28 | 3 | 0.1 | 0.22 | 3 | 1.51 | 0.9 |
| ΔARAT(A) | 16 | 5.14 | 0.96 | 8 | 5.72 | 0.95 | 16 | 7.01 | 0.92 |
| ΔBI | 3 | 0.05 | 0.1 | 7 | 4.59 | 0.64 | 8 | 3.82 | 0.75 |
| ΔSIS(ADL) | 4 | 9.45 | 0.43 | 5 | 13.38 | 0.22 | 4 | 14.1 | 0.13 |
| ΔSIS(HF) | 5 | 16.15 | 0.78 | 5 | 23.48 | 0.51 | 4 | 15.1 | 0.8 |
| ΔSIS(Mob) | 4 | 9.77 | 0.03 | 7 | 9.4 | 0.54 | 5 | 10.51 | 0.43 |
| ΔSIS(PS) | 4 | 16.36 | 0.37 | 4 | 13.52 | 0.32 | 8 | 12.53 | 0.41 |
Specific correlates are listed in Table 7. (
) = significant against chance-level based on permutation-test (p < 0.05); T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.
List of Δrs-FC correlates of Δbehavior between all pairs of time-points identified by using linear-kernel SVR are presented below.
| 1 | R.Thal-R.SMA | L.SMA-L.PMC | L.SMA-R.PMC | R.PMC-R.M1 | L.SMA-R.M1 | R.Thal-L.PMC | L.Thal-L.M1 | R.PMC-L.M1 |
| 2 | R.Thal-R.M1 | L.Thal-R.PMC | L.Thal-L.M1 | R.SMA-L.SMA | L.SMA-L.PMC | L.Thal-L.PMC | R.SMA-R.M1 | |
| 3 | R.SMA-R.PMC | R.PMC-L.M1 | R.PMC-L.M1 | L.SMA-L.PMC | L.PMC-L.M1 | |||
| 4 | L.Thal-R.PMC | L.SMA-R.M1 | L.Thal-R.SMA | |||||
| 5 | L.SMA-R.PMC | L.PMC-R.M1 | ||||||
| 6 | R.M1-L.M1 | |||||||
| 7 | L.Thal-R.PMC | |||||||
| 1 | R.Thal-L.SMA | L.Thal-R.PMC | R.Thal-R.M1 | L.Thal-L.M1 | R.Thal-L.PMC | L.Thal-R.PMC | R.Thal-R.SMA | R.Thal-L.M1 |
| 2 | L.Thal-R.PMC | R.Thal-R.M1 | R.SMA-L.M1 | L.PMC-L.M1 | L.Thal-L.PMC | L.PMC-L.M1 | ||
| 3 | R.PMC-R.M1 | R.SMA-R.M1 | R.SMA-R.PMC | L.Thal-L.M1 | R.Thal-R.PMC | |||
| 4 | R.PMC-L.PMC | R.SMA-R.M1 | R.Thal-L.SMA | L.SMA-L.M1 | ||||
| 5 | L.SMA-L.M1 | L.SMA-R.M1 | ||||||
| 1 | L.SMA-L.PMC | R.PMC-R.M1 | R.Thal-R.SMA | R.SMA-R.M1 | L.Thal-R.SMA | R.SMA-L.SMA | L.Thal-L.M1 | L.SMA-L.M1 |
| 2 | L.SMA-R.PMC | R.PMC-L.PMC | L.Thal-R.SMA | R.Thal-R.M1 | L.Thal-R.M1 | L.PMC-R.M1 | L.Thal-L.SMA | L.Thal-L.M1 |
| 3 | R.M1-L.M1 | L.SMA-R.PMC | R.SMA-R.PMC | R.PMC-L.M1 | R.Thal-R.PMC | R.SMA-R.M1 | R.Thal-L.PMC | L.SMA-L.PMC |
| 4 | R.SMA-L.M1 | R.SMA-L.PMC | R.SMA-R.M1 | L.SMA-L.M1 | R.Thal-L.PMC | L.Thal-R.PMC | L.Thal-R.PMC | |
| 5 | L.Thal-L.M1 | R.PMC-L.PMC | R.PMC-L.M1 | R.SMA-R.PMC | R.Thal-R.SMA | L.Thal-L.SMA | ||
| 6 | L.Thal-L.SMA | L.SMA-L.PMC | L.Thal-L.M1 | L.PMC-L.M1 | R.PMC-R.M1 | L.PMC-L.M1 | ||
| 7 | L.Thal-L.PMC | |||||||
| 8 | L.PMC-R.M1 | |||||||
| 1 | R.Thal-R.SMA | NIHSS | L.SMA-R.PMC | R.Thal-L.M1 | L.SMA-R.M1 | R.PMC-L.M1 | NIHSS | R.PMC-L.M1 |
| 2 | Gender | R.Thal-L.PMC | L.Thal-R.PMC | L.Thal-R.M1 | L.SMA-L.M1 | R.Thal-L.PMC | Motor Imp. | R.Thal-L.SMA |
| 3 | R.SMA-L.M1 | L.SMA-R.PMC | TSS | R.PMC-R.M1 | R.SMA-L.SMA | R.SMA-L.M1 | L.SMA-R.PMC | R.Thal-R.SMA |
| 4 | R.Thal-R.M1 | R.M1-L.M1 | L.SMA-R.M1 | L.Thal-R.M1 | R.Thal-L.PMC | L.Thal-R.M1 | ||
| 5 | R.Thal-L.PMC | Lesion Hemi | R.SMA-L.PMC | |||||
| 6 | R.Thal-L.SMA | |||||||
| 7 | L.SMA-L.PMC | |||||||
| 8 | L.SMA-L.M1 | |||||||
| 9 | R.Thal-R.SMA | |||||||
| 10 | R.PMC-R.M1 | |||||||
| 11 | L.SMA-R.M1 | |||||||
| 12 | R.M1-L.M1 | |||||||
| 13 | R.SMA-R.M1 | |||||||
| 14 | L.Thal-L.M1 | |||||||
| 15 | R.PMC-L.M1 | |||||||
| 16 | TSS | |||||||
| 1 | R.Thal-L.SMA | R.SMA-R.PMC | Motor Imp. | R.Thal-R.M1 | R.SMA-L.M1 | L.PMC-L.M1 | L.Thal-L.PMC | R.Thal-L.M1 |
| 2 | NIHSS | R.Thal-R.M1 | R.Thal-R.M1 | Age | R.Thal-L.PMC | L.Thal-R.PMC | NIHSS | L.PMC-L.M1 |
| 3 | R.Thal-R.PMC | Lesion Hemi | L.SMA-R.PMC | L.Thal-L.M1 | R.PMC-L.M1 | R.SMA-R.M1 | R.SMA-L.M1 | R.Thal-R.PMC |
| 4 | R.SMA-L.M1 | R.Thal-L.SMA | Lesion Hemi | L.Thal-L.M1 | R.Thal-R.SMA | L.Thal-R.PMC | ||
| 5 | R.SMA-R.PMC | L.Thal-L.PMC | R.M1-L.M1 | R.Thal-L.M1 | R.SMA-L.M1 | |||
| 6 | Motor Imp. | R.Thal-L.PMC | L.Thal-R.PMC | |||||
| 7 | L.Thal-R.SMA | NIHSS | L.PMC-R.M1 | |||||
| 8 | L.SMA-L.PMC | |||||||
| 1 | R.Thal-R.SMA | R.PMC-R.M1 | L.SMA-L.PMC | R.SMA-R.M1 | L.SMA-R.M1 | R.SMA-L.SMA | L.Thal-L.SMA | L.SMA-L.M1 |
| 2 | L.PMC-L.M1 | L.SMA-R.PMC | R.SMA-R.M1 | R.Thal-R.M1 | Lesion Hemi | L.PMC-R.M1 | L.Thal-L.PMC | L.Thal-L.M1 |
| 3 | R.PMC-L.PMC | R.SMA-L.PMC | L.SMA-R.M1 | Motor Imp. | R.SMA-L.PMC | L.Thal-L.PMC | L.Thal-L.M1 | R.SMA-R.PMC |
| 4 | L.Thal-L.PMC | R.Thal-L.Thal | R.Thal-L.Thal | R.Thal-L.PMC | R.SMA-R.PMC | R.Thal-L.Thal | ||
| 5 | R.PMC-L.M1 | L.Thal-R.PMC | R.SMA-L.M1 | Age | ||||
| 6 | L.SMA-L.M1 | R.Thal-L.SMA | TSS | |||||
| 7 | L.PMC-L.M1 | R.Thal-R.PMC | L.PMC-R.M1 | |||||
| 8 | NIHSS | L.Thal-R.M1 | L.SMA-L.M1 | |||||
| 9 | R.Thal-L.Thal | |||||||
| 10 | R.M1-L.M1 | |||||||
| 11 | L.PMC-L.M1 | |||||||
| 12 | Gender | |||||||
| 13 | L.Thal-R.SMA | |||||||
| 14 | NIHSS | |||||||
| 15 | L.Thal-R.PMC | |||||||
| 16 | L.Thal-R.M1 | |||||||
Linear-kernel SVR performances based on leave-one out cross-validation to correlate behavioral measures at preceding time-point and clinical variables with behavioral measures at succeeding time-point are presented.
| 9HPT(A) | 2 | 2.52 | 0.74 | 1 | 3.28 | 0.52 | 3 | 3.25 | 0.53 |
| 9HPT(U) | 4 | 37.36 | 0.91 | 5 | 23.4 | 0.97 | 5 | 9.05 | 0.99 |
| ARAT(A) | 3 | 2.73 | 0.99 | 3 | 3.31 | 0.98 | 3 | 3.13 | 0.98 |
| BI | 1 | 5.48 | 0.62 | 2 | 5.19 | 0.54 | 3 | 4.83 | 0.6 |
| SIS(ADL) | 3 | 8.56 | 0.54 | 3 | 10.24 | 0.54 | 3 | 11.42 | 0.43 |
| SIS(HF) | 4 | 12.74 | 0.86 | 4 | 13.03 | 0.85 | 4 | 7.9 | 0.94 |
| SIS(Mob) | 4 | 5.36 | 0.71 | 2 | 11.8 | 0.28 | 3 | 10.09 | 0.47 |
| SIS(PS) | 2 | 14.7 | 0.49 | 2 | 12.03 | 0.46 | 3 | 8.85 | 0.71 |
Specific correlates are listed in Table 9. (
) = significant against chance-level based on permutation-test (p < 0.05); T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.
List of behavioral and clinical correlates at preceding time-points using linear-kernel SVR for estimation of measures at succeeding time-points are presented below.
| 1 | 9HPT(A) | 9HPT(U) | Motor Imp. | SIS(ADL) | SIS(HF) | SIS(Mob) | SIS(PS) | BI |
| 2 | NIHSS | Motor Imp. | ARAT(A) | Lesion Hemi | NIHSS | NIHSS | NIHSS | |
| 3 | NIHSS | NIHSS | NIHSS | TSS | TSS | |||
| 4 | Lesion Hemi | Motor Imp. | Lesion Hemi | |||||
| 1 | 9HPT(A) | 9HPT(U) | ARAT(A) | SIS(ADL) | SIS(HF) | SIS(Mob) | SIS(PS) | BI |
| 2 | NIHSS | Motor Imp. | Motor Imp. | NIHSS | Motor Imp. | Motor Imp. | TSS | |
| 3 | Motor Imp. | NIHSS | TSS | TSS | ||||
| 4 | Lesion Hemi | Motor Imp. | ||||||
| 5 | TSS | |||||||
| 1 | 9HPT(A) | 9HPT(U) | ARAT(A) | SIS(ADL) | SIS(HF) | SIS(Mob) | SIS(PS) | BI |
| 2 | TSS | Lesion Hemi | Motor Imp. | Motor Imp. | Motor Imp. | Motor Imp. | Age | TSS |
| 3 | Motor Imp | Motor Imp. | NIHSS | TSS | NIHSS | NIHSS | Motor Imp. | Motor Imp. |
| 4 | TSS | TSS | ||||||
| 5 | NIHSS | |||||||
T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.